Target 18: By 2021, rules and regulations adhering to the precautionary approach for biosafety are available and applied by relevant agencies for improvement and development of rules, procedures and mechanisms to regulate transboundary movement of livin

The national biosafety guideline for modern biotechnology was developed in order to provide a framework which is consistence to both the criteria of internationally recognized organizations and the pre-existing national regulations of relevance. However Thailand is still without specific legislation to regulate adverse impacts from modern biotechnology to biodiversity, remaining uncertain in addressing liability and redress of biodiversity damage derived from transboundary movement, transit, handling and use of Genetically Modified Organisms (GMOs). In addition, further building of biosafety capacity is required for public agencies, private sector and the general publics in implementing the Cartagena Protocol on Biosafety.